169 related articles for article (PubMed ID: 35987846)
1. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract][Full Text] [Related]
2. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics.
Pandian J; Ganesan K
Exp Cell Res; 2022 Jan; 410(1):112956. PubMed ID: 34864005
[TBL] [Abstract][Full Text] [Related]
3. Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes.
Balakrishnan K; Ganesan K
Med Oncol; 2022 Jun; 39(9):132. PubMed ID: 35723749
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
5. Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis.
Al-Marzoqee FY; Khoder G; Al-Awadhi H; John R; Beg A; Vincze A; Branicki F; Karam SM
Int J Oncol; 2012 Nov; 41(5):1733-43. PubMed ID: 22922943
[TBL] [Abstract][Full Text] [Related]
6. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.
Kalamohan K; Periasamy J; Bhaskar Rao D; Barnabas GD; Ponnaiyan S; Ganesan K
Mol Oncol; 2014 Oct; 8(7):1306-25. PubMed ID: 24917244
[TBL] [Abstract][Full Text] [Related]
8. YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates.
Bhaskar Rao D; Panneerpandian P; Balakrishnan K; Ganesan K
J Cell Commun Signal; 2021 Jun; 15(2):251-267. PubMed ID: 33620645
[TBL] [Abstract][Full Text] [Related]
9. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.
Yong X; Tang B; Xiao YF; Xie R; Qin Y; Luo G; Hu CJ; Dong H; Yang SM
Cancer Lett; 2016 May; 374(2):292-303. PubMed ID: 26940070
[TBL] [Abstract][Full Text] [Related]
11. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
13. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
14. Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways.
Yuan F; Zhou W; Zou C; Zhang Z; Hu H; Dai Z; Zhang Y
Mol Cell Biochem; 2010 Oct; 343(1-2):155-62. PubMed ID: 20549546
[TBL] [Abstract][Full Text] [Related]
15. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
16. Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes.
Bhaskar Rao D; Devanandan HJ; Ganesan K
Drug Dev Res; 2021 Dec; 82(8):1182-1192. PubMed ID: 34002415
[TBL] [Abstract][Full Text] [Related]
17. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
[TBL] [Abstract][Full Text] [Related]
19. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
Panneerpandian P; Devanandan HJ; Marimuthu A; Karthikeyan C; Ganesan K
Antiviral Res; 2020 Feb; 174():104695. PubMed ID: 31846633
[TBL] [Abstract][Full Text] [Related]
20. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]